| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.59B | +32.2% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.00B | — |
| Gross margin | 15.9% | Net margin 0.6% |
| Revenue Q/Q | -12.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.50B | 84.1% |
| R&D | ¥0.02B | 3.1% |
| SG&A | ¥0.04B | 7.1% |
| Tax & other | ¥0.00B | 0.7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
盛帮股份 ・ 五洲医疗 ・ 华康洁净 ・ 和顺科技 ・ 瑞泰新材 ・ 普瑞眼科 ・ 宏源药业 ・ 杰创智能 ・ 威尔高 ・ 同星科技 ・ 通力科技 ・ 华融化学
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies